주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
상단영역
UPDATE : 2024-04-29 10:39 (Mon)
Home
Log in
Join
전체메뉴
기사검색
검색
본문영역
Policy
목록
(
총 :
695 )
기사목록 보기 형태
제목형
요약형
포토형
Expectations rise on Assembly’s discussion to permit ‘non-contact’ treatment
Kwak Sung-sun By
2022.07.25 12:25
Nearly one-third of Covid-19 reinfections occur in children, adolescents
Lee Han-soo
2022.07.22 17:24
Korean heart failure society unveils new treatment guideline
Lee Han-soo
2022.07.22 17:23
312 civic groups urge Yoon to raise Korea’s contribution to ‘Global Fund’
Kim Ju-yeon
2022.07.22 11:47
Korea confirms efficacy of Covid-19 treatments for 4 Omicron subvariants
Lee Han-soo
2022.07.21 18:09
‘Rapid new drug review should continue even after Covid-19’
Kim Chan-hyuk
2022.07.21 16:52
Ultra-expensive SMA drug Zolgensma to get insurance benefits from August
Kim Yun-mi
2022.07.21 12:22
Korea braces for 300,000 daily Covid-19 cases by securing 4,000 more sickbeds
Lee Han-soo
2022.07.20 18:24
New Covid-19 cases jump to 83-day high as BA.5 emerges as dominant strain
Lee Han-soo
2022.07.19 18:32
‘Pandemic-caused social, economic changes raised suicidal risk’
Kwak Sung-sun
2022.07.19 16:21
Civic group lashes at Yoon administration's quarantine policy as 'unscientific and irresponsible'
Lee Han-soo
2022.07.18 18:24
20% of school-age children are obese in Seoul
Kwak Sung-sun
2022.07.18 15:56
처음
이전
이전
이전
51
52
53
54
55
56
57
58
끝
위로
전체메뉴
All
Hospital
Pharma
Bio
All
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
All
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
ASCO 2020 Highlights
Special Series in Celebration of KBR’s 4th Anniversary
KBR Covering RSNA 2021
Special Series in Celebration of KBR’s 5th Anniversary
Special Report on EULAR 2022
[Top K-Pharma Analysis]
BIO 2023
Opinion
All
Reporter’s Notebook
Journalist’s Column
Congratulatory Remarks
Sponsored
전체메뉴닫기